After spinning of its consumer health company this year for the creation of Kenvue, Johnson & Johnson announced it is updating its brand, uniting both its medtech and pharmaceutical segments under the Johnson & Johnson brand name to demonstrate its collective power in healthcare.
“Our exclusive focus on Innovative Medicine and MedTech solutions enables us to innovate across the full spectrum of healthcare in ways no other company can,” said Joaquin Duato, chairman of the board and CEO. “Uniting our diverse businesses under an updated Johnson & Johnson brand reflects our unique ability to reimagine healthcare through transformative innovation, while staying true to Our Credo values and the level of care that patients and doctors expect of us.”
Moving forward, the company’s two segments will be more connected to the Johnson & Johnson brand. Over time, Janssen, the company’s pharmaceutical segment, will be named Johnson & Johnson Innovative Medicine, and the medical technology segment will continue to be named Johnson & Johnson MedTech.
Johnson & Johnson Innovative Medicine addresses the most complex diseases in the areas of Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina and to develop the potential medicines of tomorrow.
The medical technology segment is working to solve pressing healthcare challenges through innovations at the intersection of biology and technology. Johnson & Johnson MedTech is harnessing its deep expertise in surgery, orthopedics, vision, and interventional solutions to develop healthcare solutions that are smarter, less invasive, and more personalized.
The new Johnson & Johnson brand identity builds on the company’s legacy, while also modernizing key elements to showcase healthcare innovation in a way that’s inclusive and brings the Company’s warm, caring nature to life.
Johnson & Johnson’s new logo is modernized for this next chapter. Each letter is drawn in one pen stroke. The Company will embrace both the long- and short-form versions of the logo, expanding and building more equity around a short-form ‘J&J’.
The company will continue to leverage the color red, leaning into a refreshed, bright, and contemporary color.
According to J&J, the logo and brand have crafted to spark energy, optimism and inclusivity, all while offering a unique and distinctive approach in healthcare.
“Our Johnson & Johnson brand identity communicates our bold approach to innovation in healthcare, while staying true to the care we have for our patients around the world,” said Vanessa Broadhurst, executive vice president of global corporate affairs. “We take immense pride in leading healthcare for more than a century and are seizing on our scientific momentum to profoundly impact health for humanity.”
The new logo, colors, and font will be rolled out across all company materials, product packaging, and branding assets over time.
To access more business news, visit NJB News Now.
Related Articles: